{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-049748","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.374395+00:00","generated_at":"2026-05-15T00:41:10.800317+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CFO Ronald McClurg to retire June 30, 2026; COO Christopher Volker to succeed as CFO","bullets":["Ronald McClurg to retire as CFO effective June 30, 2026, then serve as Senior Advisor until Dec 31, 2026.","Christopher Volker, current COO, appointed CFO effective July 1, 2026; base salary increased to $350,000.","Volker brings medtech experience from Abbott, CSI, St. Jude Medical; holds Wharton MBA and CFA.","McClurg entered Transition and Release Agreement dated April 28, 2026; will receive salary/benefits through retirement and provide general release.","McClurg's equity awards (options/RSUs) continue per plan terms; no immediate change to equity."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-049748","json":"https://secwatch.observer/filing/0001213900-26-049748.json","markdown":"https://secwatch.observer/filing/0001213900-26-049748.md","text":"https://secwatch.observer/filing/0001213900-26-049748.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026049748/0001213900-26-049748-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026049748/ea0288229-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:41:10.800317+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"012c163b8b","claim":"Christopher Volker was appointed as Chief Financial Officer at NEUROONE MEDICAL TECHNOLOGIES Corp.","evidence_excerpt":"the Board announced that Christopher Volker, the Company’s Chief Operating Officer, will succeed Mr. McClurg as the Company’s Chief Financial Officer effective as of July 1, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026049748/0001213900-26-049748-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"3f81748d19","claim":"Ronald McClurg departed as Chief Financial Officer at NEUROONE MEDICAL TECHNOLOGIES Corp.","evidence_excerpt":"On April 24, 2026, Ronald McClurg notified NeuroOne Medical Technologies Corporation (the \"Company\") of his intention to retire as the Company’s Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026049748/0001213900-26-049748-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}